Negative finish to the week but all eyes on strong quarterly performance

Published 03-APR-2017 12:18 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

While the Dow closed the week on a negative note, shedding circa 60 points all the focus was on the quarter on quarter gain. The index finished the December quarter on 19,763 points, and went on to post a 900 point rally in the March quarter to close at 20,663 points on Friday.

Even more impressive is the year-on-year increase of nearly 3000 points, representing a gain of nearly 17%.

The NASDAQ has also acquitted itself well, only falling three points on Friday and sitting not far below the record high that was set in March, representing an increase of nearly 10% for the quarter.

It was a similar story in the UK as the index recorded a decline of 0.6%, finishing at 7322 points. Mining stocks placed a significant drag on the index. GDP data was relatively weak with the economy growing 0.7% in the December quarter of 2016.

However, once again the focus was on the sustained increase over the last three months with the index recording its fourth straight quarterly rise, finishing the quarter at 7322 points.

Mainland European markets continued their bullish run with the DAX surging 0.5% to close at 12,312 points as it marches towards the the psychological 12,400 mark.

The Paris CAC 40 also rallied strongly, increasing 33 points or 0.65% to close at 5122 points, a level it last struck in August 2015.

On the base metals front, copper came off slightly, but still closed in positive territory on a week on week basis. Zinc continued its decline, falling from a mid-week high of US$1.28 per pound to US$1.24 per pound.

Nickel and lead made slight gains with the latter just shy of the high of US$1.07 per pound that it struck the previous week after a strong surge.

Supply demand dynamics still look robust for lead with LME warehouse stocks having fallen from approximately 196,000 tonnes in December 2016 to 189,000 tonnes as at the end of March.

Gold continues to hover in the vicinity of US$1250 per ounce, having gained 0.3% on Friday.

Oil also continued its rally, gaining 1% to US$50.85 per barrel.

The Australian dollar is fetching US$0.762, having come off slightly on Friday.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X